Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia
https://doi.org/10.15829/1560-4071-2022-5014
Abstract
Repetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular.
Aim. To evaluate the control of HTN in the Russian population during the COVID-19 period based on the results of screening for HTN May Measurement Month 2021 (MMM2021).
Material and methods. During May-August 2021, 2491 participants from 11 Russian regions took part in the screening. Participation was voluntary without restrictions on sex. All participants were over 18 years of age. During the screening, blood pressure (BP) was measured three times using automatic and mechanical BP monitors. In addition, a questionnaire was filled out on behavioral risk factors, comorbidities and therapy. HTN was diagnosed with systolic BP ≥140 mmHg and/ or diastolic blood pressure ≥90 mmHg and/or taking antihypertensive therapy. The questionnaire included questions about prior COVID-19, vaccinations and their impact on the intake of antihypertensive drugs.
Results. The analysis included data from 2461 respondents aged 18 to 92, of which 963 were men (39,1%). The proportion of hypertensive patients was 41,0%, while among them 59,0% took antihypertensives and 30,9% were effectively treated. In comparison with pre-pandemic period according to MMM2018-2019, the higher proportion of HTN patients in the Russian sample was revealed during MMM2021 (41,0% vs 31,3%, p<0,001) with a comparable proportion of patients receiving antihypertensive therapy (60,7% vs 59,0%, p=0,05) and treatment efficacy (28,7% vs 30,9%, p=0,36). Monotherapy was received in 44,7% of cases, while dual and triple combination therapy — in 30,9% and 14,1%, respectively. The majority of respondents (~90%) did not adjust their antihypertensive therapy during the COVID-19 pandemic.
Conclusion. According to HTN screening in Russia, there is persistent ineffective control of HTN, which may be due to both the worsening pattern of behavioral risk factors, limited access to healthcare during COVID-19, and the inertia of physicians and low adherence of patients due to the asymptomatic HTN course in the majority.
About the Authors
O. P. RotarRussian Federation
Oxana P. Rotar - MD, PhD, Head of scientific laboratory “Epidemiology of non-communicable diseases” of Almazov National Medical Research Centre; Leading Researcher of the Research Department of Genetic Risks and Personalized Prevention of the Research Laboratory of Population Genetics of WCRC for Personalized Medicine.
St. Petersburg.
Researcher ID: A-3670-2014
Competing Interests:
No
A. M. Erina
Russian Federation
MD, researcher of the Research Department of Genetic Risks and Personalized Prevention of the Research Laboratory of Population Genetics of WCRC for Personalized Medicine, contribution: data collection, final approval of the manuscript for publication.
St. Petersburg.
Research ID: AAH-1857-2019
Competing Interests:
No
M. A. Boiarinova
Russian Federation
St. Petersburg.
Competing Interests:
No
E. V. Moguchaia
Russian Federation
Ekaterina V. Moguchaya - MD, junior researcher of scientific laboratory “Epidemiology of non-communicable diseases” of Almazov National Medical Research Centre; junior researcher of the Research Department of Genetic Risks and Personalized Prevention of the Research Laboratory of Population Genetics of WCRC for Personalized Medicine.
St. Petersburg.
Research ID: AAH-3802-2019
Competing Interests:
No
E. P. Kolesova
Russian Federation
MD, PhD, researcher of scientific laboratory “Epidemiology of non-communicable diseases” of Almazov National Medical Research Centre; researcher of the Research Department of Genetic Risks and Personalized Prevention of the research Laboratory of Metabolic Diseases and Microbiot of WCRC for Personalized Medicine.
St. Petersburg.
Research ID: AAH-2492-2019
Competing Interests:
No
K. M. Tolkunova
Russian Federation
MD, postgraduate student of Almazov National Medical Research Centre; junior researcher of the Research Department of Genetic Risks and Personalized Prevention of the Research Laboratory of Population Genetics of WCRC for Personalized Medicine.
St. Petersburg.
Researcher ID: AAB-4484-2020
Competing Interests:
No
A. R. Gorshevaya
Russian Federation
3rd year student Almazov National Medical Research Center.
St. Petersburg.
Researcher ID: AGV-7290-2022
Competing Interests:
No
K. A. Kovalenko
Russian Federation
6th year student of the St. Petersburg State Pediatric Medical University of the Ministry of Health of Russia.
St. Petersburg.
Researcher ID: AGV-6204-2022
Competing Interests:
No
E. A. Smirnova
Russian Federation
MD, Associate Professor, Head of the Department of Internal Medicine of the Department of Internal Diseases of the I.P. Pavlov Ryazan State Medical University.
Ryazan.
Researcher ID: Y-1235-2018
Competing Interests:
No
Ya. A. Belenikina
Russian Federation
MD, Associate Professor of the Department of Internal Diseases of the I.P. Pavlov Ryazan State Medical University.
Ryazan.
Researcher ID: ABC-4551-2022
Competing Interests:
No
I. V. Bikushova
Russian Federation
Assistant of the Department of Internal Diseases of the I.P. Pavlov Ryazan State Medical University.
Ryazan.
Researcher ID: ABB-1440-2021
Competing Interests:
No
M. A. Kercheva
Russian Federation
MD, Researcher, Cardiologist, Department of Emergency Cardiology of the Tomsk National Research Medical Center.
Tomsk.
Researcher ID: O-7782-2017
Competing Interests:
No
A. V. Svarovskaya
Russian Federation
MD, Senior Researcher, Department of Myocardial Pathology of the Tomsk National Research Medical Center.
Tomsk.
Researcher ID: A-8574-2017
Competing Interests:
No
M. M. Petrova
Russian Federation
DM, Professor, Head of the Department of Polyclinic Therapy and Family Medicine with a PO сourse of the V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk.
Researcher ID: L-5623-2014
Competing Interests:
No
D. S. Kaskaeva
Russian Federation
MD, Associate Professor, head teacher. Department of Polyclinic Therapy and Family Medicine with a PO course of the V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk.
Researcher ID: S-8106-2016
Competing Interests:
No
P. A. Shcherbina
Russian Federation
6th year student of the V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, contribution: data collection.
Krasnoyarsk.
Researcher ID: AGW-0570-2022
Competing Interests:
No
S. Yu. Nikulina
Russian Federation
MD, Head of the Department of Faculty Therapy in V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk.
Researcher ID: N-7054-2014
Competing Interests:
No
A. A. Chernova
Russian Federation
MD, Professor of the Department of Faculty Therapy in V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Head of the Department of Science and Innovation of the FSBI FSCC FMBA.
Krasnoyarsk.
Researcher ID: F-3814-2016
Competing Interests:
No
A. V. Levshin
Russian Federation
MD, Chief Physician of the Asinovskaya District Hospital.
Asino, Tomsk region.
Researcher ID: AGW-9386-2022
Competing Interests:
No
A. O. Shabelsky
Russian Federation
Doctor of the Department of Medical Prevention of the Asinovskaya District Hospital.
Asino, Tomsk region.
Researcher ID: ACK-3935-2022
Competing Interests:
No
E. I. Zheleznyak
Russian Federation
MD, cardiologist, therapist, rheumatologist, assistant of the Department of Internal Diseases № 2 of the RSMU Rostov state Medical University.
Rostov-on-Don.
Researcher ID: T-6879-2017
Competing Interests:
No
E. A. Kartashova
Russian Federation
MD, cardiologist, internist, rheumatologist, Department of Associate Professor of Internal Medicine № 2 of the RSMU Rostov state Medical University.
Rostov-on-Don.
Researcher ID: T-6259-2018
Competing Interests:
No
Yu. A. Sharapova
Russian Federation
MD, Associate Professor of the Department of Hospital Therapy and Endocrinology of N.N. Burdenko Voronezh State Medical University; Associate Professor of the Department of Management in Healthcare of N.N. Burdenko Voronezh State Medical University.
Voronezh.
Researcher ID: AAB-5935-2020
Competing Interests:
No
T. M. Chernykh
Russian Federation
Professor of the Department of Hospital Therapy and Endocrinology N. N. Burdenko Voronezh State Medical University.
Voronezh.
Researcher ID: B-6281-2017
Competing Interests:
No
M. V. Derevyanchenko
Russian Federation
MD, Associate Professor, Professor of the Department of Diseases of the Pediatric and Dental Faculties, General Practitioner of the Family Medicine Clinic of Volgograd State Medical University.
Volgograd.
Researcher ID: A-1859-2016
Competing Interests:
No
V. V. Fedotov
Russian Federation
3rd year student of the 1st group at the medical faculty of Volgograd State Medical University.
Volgograd.
Competing Interests:
No
N. Yu. Shaposhnikova
Russian Federation
3rd year student of the 4th group at the pediatric faculty of Volgograd State Medical University.
Volgograd.
Competing Interests:
No
E. R. Makeeva
Russian Federation
MD, Associate Professor, Physician at the Health Center "Perspektiva" State Healthcare Institution "City Clinical Hospital of the Holy Apostle Andrew the First-Called".
Ulyanovsk.
Researcher ID: AAB-4811-2020
Competing Interests:
No
O. V. Ulitina
Russian Federation
Head of the Department of the Health Center "Perspektiva" State Healthcare Institution "City Clinical Hospital of the Holy Apostle Andrew the First-Called".
Ulyanovsk.
Competing Interests:
No
M. V. Menzorov
Russian Federation
MD, Professor of the Department of Therapy and Occupational Diseases of Ulyanovsk State University.
Ulyanovsk.
Researcher ID: D-8191-2014
Competing Interests:
No
E. M. Dolya
Russian Federation
Associate Professor of the Department of V.I. Vernadsky Crimean Federal University, S.I. Georgievsky Medical Academy.
Simferopol, Republic of Crimea.
Researcher ID: AAB-5326-2020
Competing Interests:
No
A. A. Tanicheva
Russian Federation
Anastasia A. Tanicheva - Executive Director of the All-Russian Public Organization "Russian Society of Cardiology", participation in the development of the concept of work and design of the study.
St. Petersburg.
Researcher ID: AAC-5213-2020
Competing Interests:
No
A. O. Konradi
Russian Federation
Aleksandra O. Konradi - MD, PhD, Professor, corresponding member of the Russian Academy of Sciences, vice-director on scientific work of Almazov National Medical Research Centre.
St. Petersburg.
Research ID P-1547-2014
Competing Interests:
No
E. V. Shlyakhto
Russian Federation
Evgeny V. Shlyakhto - MD, PhD, Professor, Academician of the Russian Academy of Sciences, General Director of Almazov National Medical Research Centre; Director of WCRC for Personalized Medicine.
St. Petersburg.
Research ID A-6939-2014
Competing Interests:
No
References
1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-80. doi:10.1016/S0140-6736(21)01330-1.
2. Boytsov SA, Balanova YuA, Shalnova SA, et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ESSE. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ.) doi:10.15829/1728-8800-2014-4-4-14.
3. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study). Rational Pharmacotherapy in Cardiology. 2019;15(4):450-66. (In Russ.) doi:10.20996/1819-6446-2019-15-4-450-466.
4. Balanova YuA, Shalnova SA, Kutsenko VA, et al. Contribution of hypertension and other risk factors to survival and mortality in the Russian population. Cardiovascular Therapy and Prevention. 2021;20(5):3003. (In Russ.) doi:10.15829/1728-8800-2021-3003.
5. Churilova E, Shkolnikov VM, Shalnova SA, et al. Long-term trends in blood pressure and hypertension in Russia: an analysis of data from 14 health surveys conducted in 1975-2017. BMC Public Health. 2021;21(1):2226. doi:10.1186/s12889-021-12320-4.
6. Beaney T, Schutte AE, Stergiou GS, on behalf of MMM Investigators. May Measurement Month 2019. The global blood pressure screening campaign of the International Society of Hypertension. Hypertension. 2020;76:333-41.
7. Rotar О, Konradi А, Tanicheva А, et al. May Measurement Month 2017 in Russia: hypertension treatment and control — Europe. European Heart Journal Supplements. Eur Heart J Suppl. 2019;21(D):D101-D103. doi:10.1093/eurheartj/suz068.
8. Rotar OP, Tolkunova KM, Solntsev VN, et al. May Measurement Month 2019: adherence to treatment and hypertension control in Russia. Russian Journal of Cardiology. 2020;25(3):3745. (In Russ). doi:10.15829/1560-4071-2020-3-3745.
9. Kreutz R, Dobrowolski P, Prejbisz A, et al. European Society of Hypertension COVID-19 Task Force Review. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077-89. doi:10.1097/HJH.0000000000002770.
10. Beaney T, Schutte AE, Tomaszewski M, on behalf of the MMM Investigators. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6(7):e736-e743. doi:10.1016/S2214-109X(18)30259-6.
11. Beaney T, Burrell LM, Castillo RR, et al.; MMM Investigators. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019;40(25):2006-201. doi:10.1093/eurheartj/ehz300.
12. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up. Russian Journal of Cardiology. 2021;26(10):4708. (In Russ.) doi:10.15829/1560-4071-2021-4708.
13. The Lancet Gastroenterology Hepatology. Drinking alone: COVID-19, lockdown, and alcohol-related harm. Lancet Gastroenterol Hepatol. 2020;5(7):625. doi:10.1016/S2468-1253(20)30159-X.
14. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700-12. doi:10.1016/S0140-6736(21)02143-7.
15. Fragoulis C, Dimitriadis K, Siafi E et al. Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry. Eur J Prev Cardiol. 2022;29(1):194-201. doi:10.1093/eurjpc/zwab159.
16. Karamnova NS, Maksimov SA, Shalnova SA, et al. Hypertension and dietary patterns of the adult population. Results of the Russian epidemiological study ESSE-RF. Cardiovascular Therapy and Prevention. 2020;19(5):2570. (In Russ.) doi:10.15829/1728-8800-2020-2570.
17. Drapkina OM, Shepel RN, Drozdova LYu, et al. Quality of follow-up monitoring of the adult population with grade 1-3 hypertension, with the exception of resistant hypertension, by primary care physicians in different Russian regions. Russian Journal of Cardiology. 2021;26(4):4332. (In Russ.) doi:10.15829/1560-4071-2021-4332.
18. Interim guidelines. Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19). Version 15 (22.02.2022). (In Russ.) https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/%D0%92%D0%9C%D0%A0_COVID-19_V15.pdf.
Supplementary files
Review
For citations:
Rotar O.P., Erina A.M., Boiarinova M.A., Moguchaia E.V., Kolesova E.P., Tolkunova K.M., Gorshevaya A.R., Kovalenko K.A., Smirnova E.A., Belenikina Ya.A., Bikushova I.V., Kercheva M.A., Svarovskaya A.V., Petrova M.M., Kaskaeva D.S., Shcherbina P.A., Nikulina S.Yu., Chernova A.A., Levshin A.V., Shabelsky A.O., Zheleznyak E.I., Kartashova E.A., Sharapova Yu.A., Chernykh T.M., Derevyanchenko M.V., Fedotov V.V., Shaposhnikova N.Yu., Makeeva E.R., Ulitina O.V., Menzorov M.V., Dolya E.M., Tanicheva A.A., Konradi A.O., Shlyakhto E.V. Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia. Russian Journal of Cardiology. 2022;27(4):5014. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5014